Today: 11 June 2026
Browse Category

NASDAQ:IOVA 3 November 2025 - 23 December 2025

Iovance Biotherapeutics (IOVA) Stock News Today: Barclays Raises Target, Short-Interest Pressure, and 2026 Catalysts (Dec. 23, 2025)

Iovance Biotherapeutics (IOVA) Stock News Today: Barclays Raises Target, Short-Interest Pressure, and 2026 Catalysts (Dec. 23, 2025)

Iovance Biotherapeutics shares jumped 12.1% to close at $2.78 on Dec. 22, with pre-market trading near $2.80. Short interest stands at 33.4% of the float, or about 118.94 million shares, according to MarketBeat. Barclays raised its price target to $10 and kept an Overweight rating. Iovance also announced inducement stock options for four new employees at a $2.46 exercise price.
23 December 2025
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics reported Q3 2025 revenue of $67.5 million, up 13% sequentially but below analyst expectations, and a net loss of $91.3 million, or $0.25 per share. Gross margin rose to 43%. Management reaffirmed full-year revenue guidance of $250–$300 million. Over 80 U.S. treatment centers are now active, and cash reserves totaled $307 million at quarter’s end.
6 November 2025
···
Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Iovance shares traded near $2.00 on Nov. 3, 2025, with a market cap around $700 million after plunging 70% year-to-date. The company’s Amtagvi, the first FDA-approved TIL therapy for advanced melanoma, also secured Health Canada approval. Interim Phase 2 data showed a 25.6% response rate for lifileucel in advanced NSCLC. Iovance will hold its Q3 earnings call on Nov. 6.
3 November 2025

Stock Market Today

  • Nifty50 Volatility Exposes Limits of Quantitative Stock Scores
    June 11, 2026, 12:38 PM EDT. The Nifty50 index shows increased volatility amid geopolitical tensions and macroeconomic headwinds, challenging the effectiveness of quantitative stock scoring systems like Refinitiv's Stock Reports Plus. These models, which rate stocks on a 1-to-10 scale based on historical earnings and momentum, are lagging due to sudden shocks including RBI growth forecast cuts and soaring crude prices. Investors relying solely on these scores face risks as algorithmic models cannot fully capture qualitative factors such as management quality or regulatory risks. Recent breaks below the 23,000 support highlight indiscriminate selling, undermining sector rotation strategies based on back-tested data. Market participants are advised to treat quantitative scores as a due diligence tool amid tightening macroeconomic pressures and focus more on firms with strong pricing power.

Latest articles

IREN Bounces After Needham Cuts Targets, Market Watches AI Cloud Moves

IREN Bounces After Needham Cuts Targets, Market Watches AI Cloud Moves

11 June 2026
IREN shares jumped over 5% midday after two steep declines, as investors weighed Needham’s cut to 2026–27 estimates—citing slower AI cloud revenue ramp—against IREN’s $3.65B GPU financing and major AI contracts. Despite the rebound, the stock remains well below its 52-week high, with analysts focused on the timing of AI revenue recognition amid the company’s shift away from Bitcoin mining.
Plug Power Drops as Market Watches Profit Path After Meeting

Plug Power Drops as Market Watches Profit Path After Meeting

11 June 2026
Plug Power shares slid nearly 3% to $2.78, extending a six-session losing streak, as investors weighed new annual-meeting materials outlining EBITDAS-positive results exiting 2026, positive operating income exiting 2027, and overall profitability exiting 2028, amid ongoing concerns about recent volatility, cash use, and liquidity moves.
Everbright Digital Jumps; EDHL Trading Surges on Nasdaq Micro-Caps

Everbright Digital Jumps; EDHL Trading Surges on Nasdaq Micro-Caps

11 June 2026
EDHL soared $4.49 to $7.99 on volume over 53.6 million shares, outpacing major indexes, as Investing.com cited momentum-driven retail trading in a micro-cap with just 1.67 million shares outstanding and no formal company catalyst; Everbright Digital recently reported a 32.6% sales drop, a $2.25 million loss, and ended 2025 with $3,167 in cash.
Go toTop